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Osteoarticular brucellosis is the most common presentation of human active
disease although its prevalence varies widely. The three most common forms of
osteoarticular involvement are sacroiliitis, spondylitis, and peripheral arthritis. The
molecular mechanisms implicated in bone damage have been recently elucidated.
B. abortus induces bone damage through diverse mechanisms in which TNF-α and
the receptor activator of nuclear factor kappa-B ligand (RANKL)-the natural modulator
of bone homeostasis are involved. These processes are driven by inflammatory cells,
like monocytes/macrophages, neutrophils, Th17 CD4+ T, and B cells. In addition,
Brucella abortus has a direct effect on osteoarticular cells and tilts homeostatic bone
remodeling. These bacteria inhibit bone matrix deposition by osteoblasts (the only
bone cells involved in bone deposition), and modify the phenotype of these cells
to produce matrix metalloproteinases (MMPs) and cytokine secretion, contributing to
bone matrix degradation. B. abortus also affects osteoclasts (cells naturally involved
in bone resorption) by inducing an increase in osteoclastogenesis and osteoclast
activation; thus, increasing mineral and organic bone matrix resorption, contributing
to bone damage. Given that the pathology induced by Brucella species involved
joint tissue, experiments conducted on synoviocytes revealed that besides inducing
the activation of these cells to secrete chemokines, proinflammatory cytokines and
MMPS, the infection also inhibits synoviocyte apoptosis. Brucella is an intracellular
bacterium that replicates preferentially in the endoplasmic reticulum of macrophages.
The analysis of B. abortus-infected synoviocytes indicated that bacteria also replicate
in their reticulum suggesting that they could use this cell type for intracellular replication
during the osteoarticular localization of the disease. Finally, the molecular mechanisms of
osteoarticular brucellosis discovered recently shed light on how the interaction between
B. abortus and immune and osteoarticular cells may play an important role in producing
damage in joint and bone.
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OSTEOARTICULAR BRUCELLOSIS- CLINICAL FEATURES
Osteoarticular brucellosis is well documented as a major public health problem in several countries,
particularly in the Middle East, the Mediterranean region and Central and South America
(Pappas et al., 2006). Although osteoarticular involvement is the most common focal complication
of brucellosis; clinical manifestations also include neurological, heart and liver complications
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(Buzgan et al., 2010). Its prevalence varies from one report to
another, but a recent study has revealed that as many as 47%
of brucellosis patients experienced osteoarticular complications
(Turan et al., 2011). It can take place at early stages of disease,
at any time during the course of illness or some features can
be present at the onset of the disease. There are three clinical
forms: peripheral arthritis, sacroiliitis, and spondylitis. Peripheral
arthritis is the most common one and it affects knees, hips, ankles,
and wrists in the context of acute infection (Pappas et al., 2005).
The clinical features include joint pain, which may be severe,
joint swelling, tenderness; increased local warmth and limitation
of movement (Gotuzzo et al., 1982; Rajapakse, 1995; Al-Eissa,
1999; Shaalan et al., 2002). Sacroiliitis also occurs in the context
of acute brucellosis. The third form of the osteoarticular disease,
spondylitis, remains extremely difficult to treat and often seems to
result in residual bone damage (Pappas et al., 2005). The lumbar
spine is the usual site of involvement.
The mechanisms involved in bone damage due to Brucella
infection are not fully understood. Bone damage can be attributed
to the direct action of the bacteria or to an immunopathological
process due to inflammation triggered by innate immunity. No
secreted proteases, toxins or lytic enzymes have been described
so far in the bacteria; therefore, it is unlikely that this fact causes a
direct deleterious effect, pointing out to innate immune responses
as the major cause of osteoarticular pathology.
INTERPLAY BETWEEN BONE AND
IMMUNE SYSTEM
The skeleton allows locomotion, calcium storage, and harboring
hematopoietic stem cells from which blood and immune cells
are derived. Although bone appears to be metabolically inert,
it is actually a dynamic organ. Bone is composed of cells
and an extracellular matrix which becomes mineralized by the
deposition of calcium hydroxyapatite, which gives bone rigidity
and strength. Bone has three different cell types: osteoblasts
-or bone-forming cells-, osteoclasts -or bone-resorbing cells,
whose functions are intimately linked (Ikeda and Takeshita, 2016)
and osteocytes, which are terminally differentiated osteoblasts
embedded within the mineralized bone matrix. Bone remodeling,
a process coordinated between formation and degradation
of bone managed by osteoblasts and osteoclasts, respectively,
ensures bone homeostasis in healthy individuals. In order
to balance bone formation and resorption, osteoblasts secrete
RANKL that regulate the differentiation of osteoclasts, and
osteocytes are the source of the Wnt antagonist sclerostin, and
the Wnt signaling regulated by sclerostin regulate the activity
of osteoblast (Karner et al., 2016), and osteocytes also secrete
RANKL that regulate osteoclasts activity (Chen et al., 2015).
Several years of investigation have highlighted the interactions
between bone and immune cells as well as their overlapping
regulatory mechanisms (El-Jawhari et al., 2016). For instance,
osteoclasts originate from the same myeloid precursor cells that
give rise to macrophages and myeloid dendritic cells. On the
other hand, osteoblasts regulate hematopoietic stem cell niches
from which blood and immune cells are derived. Moreover, many
of the soluble mediators of immune cells, including cytokines
and growth factors, regulate the activities of osteoblasts and
osteoclasts.
In physiological conditions, “canonical” osteoclast formation
requires macrophage colony-stimulating factor (M-CSF) and
receptor activator factor of nuclear factor kB ligand (RANKL)
(Lampiasi et al., 2016). These cytokines act on cells of the
monocyte-macrophage lineage, inducing their fusion to form
multinucleated active resorbing cells. In the bone milieu, M-CSF
is produced by osteoblasts and bone marrow stromal cells. It
induces proliferation of osteoclast precursors, and differentiation
and survival of mature osteoclasts (Fuller et al., 1993; Tanaka
et al., 1993). M-CSF induces RANKL receptor expression, RANK,
on mononuclear osteoclast precursors which then interacts
with membrane-bound RANKL on surrounding osteoblasts and
stromal cells to initiate osteoclasts differentiation (Yasuda et al.,
1998). RANKL is present as both a transmembrane molecule
and a secreted form. Its interaction with RANK is opposed by
osteoprotegerin (OPG), a neutralizing soluble decoy receptor
produced by marrow stromal cells and osteoblasts (Grundt
et al., 2009). In addition to M-CSF and RANKL, a number
of other cytokines and growth factors are known to substitute
these two molecules and induce a “non-canonical” osteoclast
formation (Lampiasi et al., 2016). Bone-marrow-derived and
circulating osteoclast precursors are capable of differentiating
into osteoclasts in the presence of M-CSF and substitutes for
RANKL such as TNF-α, LIGHT (a receptor expressed in T
lymphocytes), APRIL (a proliferation inducing ligand), BAFF
(a B cell activating factor), the nerve growth factor, insulin-like
growth factor (IGF)-I and II, TGF-β, IL-6, IL-11, IL-8; or in
the presence of RANKL and substitutes for M-CSF such as a
vascular endothelial growth factor, placental growth factor, FLt-3
ligand and hepatocyte growth factor (Lampiasi et al., 2016).
Interestingly, IL-1, IL-7, IL-17, and IL- 23 have also been involved
in non-canonical osteoclastogenesis (Mori et al., 2013), mostly
by inducing indirectly osteoclastogenesis and promoting RANKL
release from other cells (Ikeda and Takeshita, 2016) and RANK
on osteoclast precursors (Adamopoulos et al., 2010). However,
it has been demonstrated that Th17 cells produce RANKL by
themselves (Adamopoulos et al., 2010). IL-17 also enhances
local inflammation and increases the production of inflammatory
cytokines which further promote RANKL expression and activity
(El-Jawhari et al., 2016). Most of these molecules are also involved
in the immune system regulation and this may explain some
of the cross-talk between immune and bone cells (D’Amelio
et al., 2006). On the other hand, RANKL has also been
involved in immune regulation (D’Amelio et al., 2006, 2009).
The significance of non-canonical pathways in physiological bone
resorption is uncertain. Yet, they may be important in the context
of pathological bone resorption associated with inflammatory
lesions of bone where high levels of these cytokines and growth
factors are present.
Osteoblasts are specialized mesenchymal cells, responsible
for the deposition of bone matrix and osteoclast regulation.
Osteoblasts play a very important role in creating and
maintaining skeletal architecture. They are the most important
cells regulating bone remodeling balance. Osteoblasts express the
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parathyroid hormone receptor whose binding to the hormone
can activate osteoclast activity by increasing serum calcium
levels (Rodan et al., 1981). Together with pre-osteoblasts and
stromal cells, osteoblasts produce two key factors acting on
osteoclasts: RANKL and OPG (Yasuda et al., 1998). Osteoblasts
were proposed to play a major role in haematopoiesis (Visnjic
et al., 2001). In the bone marrow, hematopoietic stem cells
intermingle with specialized microenvironments -known as
stem-cell niches aimed at maintaining their pluripotency and
self-renewal ability. Osteoblasts, on the trabecular bone surface,
have emerged as a crucial component of this niche, where long-
lived antibody-producing B cells are known to reside. CXCL12
and its receptor CXCR4 are involved in the colonization of bone
marrow by these B cells and in their retention in the bone
marrow, but the localization of CXCL12-expressing cells is not
consistent with that of osteoblasts on the trabecular bone surface
(Tokoyoda et al., 2004). As it is unclear whether the bone-forming
capacity is related to the function required for the niche, it is
necessary to carefully reconsider this function for osteoblasts.
Recently, osteoclasts have also been involved in the mobilization
of stem cells (Kollet et al., 2006), further supporting the intimate
relationship between the immune and bone systems.
Although bone is normally resistant to infection, Brucella spp.
have a tropism for the osteoarticular localization. In this review,
we report the current understanding of the interaction between
Brucella, resident bone cells and immune system cells.
Brucella AND OSTEOBLAST
Infection of murine and human osteoblasts with B. abortus
is a determining factor in the development of osteomyelitis
in bone tissue. B. abortus interacts directly with osteoblasts,
and replicates inside these cells. As a result of this interaction,
modifications occur in the osteoblast metabolism. B. abortus
inhibits osteoblast differentiation and function, leading to bone
loss. Infection induces apoptosis of osteoblasts and also inhibits
mineral and organic matrix deposition by these cells. Infection
also induces RANKL expression, the main mediator of osteoclast
differentiation. All these processes are activated through the
p38 and ERK1/2 MAPK pathway (Scian et al., 2012). TNF-
α secreted by B. abortus-infected macrophages also induces
apoptosis and inhibits matrix deposition by osteoblasts (Scian
et al., 2012). In addition, infection elicits secretion of chemokines
and metalloproteinases (MMPs) (Scian et al., 2011b, 2012). Bone
and joint damage can be the result of the inflammatory reaction
elicited by MMP activity. Locally increased levels of MMPs have
been found in arthritis associated with Lyme disease (Behera
et al., 2005) and in periodontitis due to multiple bacteria (Soder
et al., 2006). In these pathological processes the main sources
of MMPs are inflammatory infiltrating cells (Song et al., 2013).
Accordingly, in vitro studies have indicated that monocytes
and neutrophils infected with Brucella secrete MMP-9 and
proinflammatory cytokines (Zwerdling et al., 2009; Delpino et al.,
2010; Scian et al., 2011b). Osteoblasts have also been shown
to produce several MMPs, among which MMP-2 is particularly
important because it degrades type I collagen present in bones
and type II collagen present in cartilage (Burrage et al., 2006).
B. abortus infection of osteoblasts elicits GM-CSF secretion which
acts as the major mediator of the increase in MMP-2 production
detected in culture supernatants from infected osteoblasts (Scian
et al., 2011b). We have also observed an increase in the levels of
MMP activity in the synovial fluid from a patient with prepatellar
bursitis (Wallach et al., 2010). A common feature of patients with
osteoarticular brucellosis is the presence of leukocyte infiltrates
(including monocytes and neutrophils) in the synovial fluid of the
joints (Gotuzzo et al., 1982; Ibero et al., 1997; Press et al., 2002;
Kasim et al., 2004). Accordingly, B. abortus infection induces
the secretion of IL-8 and MCP-1 by osteoblasts. In conclusion,
B. abortus may modulate, directly and indirectly, osteoblast
function to increase bone resorption.
Brucella AND OSTEOCYTES
Osteocytes are the terminally differentiated forms of osteoblasts
embedded in the mineralized bone matrix (Bonewald, 2011).
For many years, the bone-bound osteocyte has been considered
to be a relatively inactive cell with an unknown role in the
bone tissue. Osteocytes are not only the most abundant cell
populations of the bone lineage, which comprise up to 95% of
bone cells in the adult skeleton, but also the central regulators of
the differentiation and activity of both osteoblasts and osteoclasts
during bone remodeling (Zhao et al., 2002). Osteocytes form an
extensive and multi-functional syncytium throughout the bone.
Their location within the matrix confers these cells the ability to
sense stress throughout the bone, and to respond accordingly.
Osteocytes respond to mechanical load by sending signals to
osteoblasts and osteoclasts in the bone and modulating their
activity. RANKL, NO and IGF-1 have been identified as such
signal factors (Prideaux et al., 2016).
In vitro studies revealed that B. abortus may invade murine
osteocytes inducing the secretion of MMP-2, RANKL, and
proinflammatory cytokines. This inflammatory response induces
bone marrow-derived monocytes to undergo osteoclastogenesis
via RANKL and TNF-α (Pesce Viglietti et al., 2016).
Osteocytes are trapped within a mineralized matrix. In
these conditions, cell-to-cell and cell-to-matrix communication
in bone cells mediated by gap junctions and hemichannels,
respectively, maintains bone homeostasis. Connexin 43 (Cx-
43) is the predominant gap junction protein in bone and it
facilitates the communication of cellular signals between cells
that are required to maintain viability of osteocytes (Civitelli,
2008; Bivi et al., 2012). B. abortus infection inhibits Cx43
expression (Pesce Viglietti et al., 2016). Cx43 deletion in
osteocyte cell culture results in increased apoptosis (Bivi et al.,
2012). Integrins also control the fate and function of cells by
influencing not only their proliferation and differentiation but
also apoptosis (Streuli, 2009). B. abortus infection reduces the
expression of Cx43 expression but does not modify integrin
expression on murine osteocytes, which results in the absence
of apoptosis (Pesce Viglietti et al., 2016). However, when
osteocytes interact with supernatants from B. abortus-infected
macrophages, the expression of Cx43 is inhibited; also, the
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expression of several integrins is affected, inducing osteocyte
apoptosis (Pesce Viglietti et al., 2016). This is not surprising
given that integrins can link the cellular cytoskeletal network to
the extracellular matrix (Geiger et al., 2001), and the detaching
of osteocytes from the surrounding extracellular matrix was
reported to induce anchorage-dependent cell death, anoikis
(Gilmore, 2005).
Taking into account that osteocytes directly control bone
remodeling, the modification of the activity of these cells by
B. abortus infection could have an important contribution to
bone damage observed during osteoarticular brucellosis.
Brucella AND FIBROBLAST-LIKE
SYNOVIOCYTES
Fibroblast-like synoviocytes are mesenchymal cells that display
many characteristics of fibroblasts (Bartok and Firestein, 2010).
These cells have been recognized as central mediators of
joint damage in inflammatory arthritis of either infectious or
noninfectious origins (Inman and Payne, 2003; Bartok and
Firestein, 2010).
Human synoviocytes infected with B. abortus secrete MMP-
2, proinflammatory cytokines, RANKL, and chemokines that can
promote the transmigration of monocytes and neutrophils and
may mediate an increase in the synovium activation (Scian et al.,
2011a). Several investigations have revealed the involvement
of RANKL in bone destruction that occurs in rheumatoid
arthritis and osteoarticular infectious diseases (Teitelbaum, 2006;
Takayanagi, 2007). Brucella infection is not the exception
as it has been demonstrated that synoviocytes infected with
B. abortus induces osteoclastogenesis via RANKL, as proved
using the natural inhibitor of osteoclastogenesis, OPG (Scian
et al., 2013).
Besides their direct pathogenic role due to the production of
proinflammatory mediators, B. abortus infection inhibits human
synoviocyte apoptosis. Smooth Brucella species have developed
several mechanisms to survive intracellularly, especially inside
macrophages. It has been demonstrated that B. abortus infects
and replicates in primary human synoviocytes (Scian et al.,
2011a); this is in line with its capacity to replicate in other
nonphagocytic cells such as osteoblasts, astrocytes, hepatocytes
and hepatic stellate cells (Delpino et al., 2009, 2012; Garcia
Samartino et al., 2010; Scian et al., 2011b). However, at variance
with these cells, infection does not induce synoviocyte apoptosis.
Moreover, it inhibits apoptosis induced by staurosporine and
by culture supernatants from B. abortus-infected macrophages
and monocytes. This inhibition occurs due to the up-regulation
of anti-apoptotic factors such as cIAP-2, clusterin, livin, and
P21/CIP/CDNK1A, and the reduction in the expression of
pro-apoptotic proteins such as P-p53(S15) and the tumor
necrosis factor (TNF) RI/TNFRSF1A (Scian et al., 2013). Thus,
B. abortus could use these cells as an alternative replicative
niche in joints. Accordingly, confocal imaging confirmed that
as in macrophages, B. abortus replicates within calnexin-positive
vacuoles in human primary synoviocytes (Scian et al., 2013).
Therefore, interactions of B: abortus and synovial fibroblast may
play an important role in the pathogenesis of osteoarticular
diseases.
INMUNE CELLS AND OSTEOARTICULAR
BRUCELLOSIS
Interactions between Macrophages and
Brucella in Osteoarticular Brucellosis
Upon infection with B. abortus, macrophages release
inflammatory mediators that are able to induce the formation
of osteoclasts from undifferentiated murine bone marrow
cells (Delpino et al., 2012). In chronic inflammatory bone
diseases such as rheumatoid arthritis, proinflammatory
cytokines TNF-α, IL-1β, and IL-6, as well as RANKL, have
been shown to be important in disease progression and bone
loss (Nair et al., 1996; Merkel et al., 1999; Kotake et al., 2001;
Haynes, 2004; Wei et al., 2005). TNF-α has been reported
to stimulate osteoclastogenesis by a RANKL-independent
mechanism (Azuma et al., 2000; Kobayashi et al., 2000).
Macrophages infection with Brucella elicits the secretion of
TNF-α, IL-1β, and IL-6 but not RANKL. Cytokine production
by macrophages and concomitant osteoclastogenesis is not
dependent on bacterial viability as both phenomena are
induced by heat-killed Brucella abortus, suggesting that a
structural component of B. abortus in responsible for such
a response. B. abortus lipoproteins seem to be determinant as
L-Omp19, a prototypical B. abortus lipoprotein (Giambartolomei
et al., 2004), mimick the phenotypic and functional changes
induced by B. abortus which lead to osteoclast activation.
This phenomenon is caused by the lipid moiety of the
protein as unlipidated Omp19 (U-Omp19) was unable to
induce proinflamatory cytokine secretion and concomitant
osteoclastogenesis. In addition, when using knockout
mice, it was determined that MyD88 and TLR2 are both
necessary to induce osteoclastogenesis by B. abortus and its
lipoproteins as revealed by L-Omp19 stimulation (Delpino et al.,
2012).
TNF-α is a potent inducer of bone resorption and it is
the main proinflammatory cytokine involved in pathological
conditions by activating mature osteoclasts (Thomson et al.,
1987; Lerner and Ohlin, 1993; Kitazawa et al., 1994). With
the use of TNFR1p55 knockout mice, it was determined that
TNF-α signaling through TNFR1 appeared to be the main
determinant of macrophage-elicited osteoclastogenesis induced
by B: abortus and its lipoproteins. The major role of TNF-α
in B. abortus-induced osteoclastogenesis was also determined
in human cells using cytokine-neutralizing antibodies (Delpino
et al., 2012). As osteoblasts and synoviocytes secrete MCP-
1 in response to B. abortus infection (Scian et al., 2011a,b),
monocytes can be attracted to the site of infection. In the
in vivo situation attracted and resident-infected monocytes/
macrophage can respond to Brucella lipoproteins with the
production of TNF-α, thus inducing osteoclastogenesis. In these
conditions, proinflammatory cytokines from bone environment
induce MCP-1 secretion by human and murine osteoblasts and
Frontiers in Microbiology | www.frontiersin.org 4 February 2017 | Volume 8 | Article 256
fmicb-08-00256 February 16, 2017 Time: 16:38 # 5
Giambartolomei et al. Osteoarticular Brucellosis
human synoviocytes. Therefore, this interaction would create a
pathological, vicious circle that exacerbates bone damage.
Role of T Cells in Brucella-Induced Bone
Loss
The interaction between T cells and osteoclasts is a critical
issue in the field of bone infectious and non-infectious diseases
(Takayanagi, 2007). Activated T cells tilt bone homeostasis and
induce bone destruction under pathological conditions such
as estrogen deficiency (Kong et al., 1999; Cenci et al., 2000;
Roggia et al., 2001; Kawai et al., 2006) and inflammation (Kong
et al., 1999; Kawai et al., 2006) as they become significant
sources of RANKL (Kong et al., 1999), TNF-α (Cenci et al.,
2000), and IL-17 (Sato et al., 2006). Although these cytokines
could induce osteoclast differentiation (Takayanagi, 2010), most
T-cell cytokines, as well as IFN-γ, IL-4 and IL-10 inhibit
osteoclastogenesis (Takayanagi, 2010). Because infiltration of T
cells into the bones and joints is a hallmark pathological finding
of osteoarticular brucellosis (Madkour, 2001b; Giambartolomei
et al., 2004), it is essential to address whether and how T cells are
linked to enhanced osteoclastic bone resorption in this form of
brucellosis.
In an in vitro model in which murine purified T cells are
influenced by the inflammatory milieu elicited by B. abortus-
infected macrophages, it was demonstrated that T cells may
promote the generation of osteoclasts. The pre-activation of
these T cells with anti-CD3 induces the secretion of IFN-
γ. However, proinflammatory mediators from B. abortus-
infected macrophages tilt this phenotype to T CD4+ cells
to secrete RANKL and IL-17 (Giambartolomei et al., 2012).
Although RANKL is the major cytokine that regulates osteoclast
differentiation (Takayanagi, 2009), in this model based on the
use of blocking anti-L-17 antibodies or osteoclast precursors
from IL17R knockout mice it was revealed that IL-17 drives
osteoclastogenesis induced by Brucella-activated T cells. In
addition, IL-6 in the inflammatory milieu from B. abortus-
infected macrophages is the cytokine that induces IL-17
secretion by T cells (Giambartolomei et al., 2012). IL-17
stimulates osteoclastogenesis indirectly through the induction
of proinflammatory cytokines (TNF-α, IL-1β, and IL-6) by
osteoclast precursors. Moreover, it was determined that, with
the use of TNFRp55 knockout mice, TNF-α is the main
proinflammatory cytokine involved in osteoclastogenesis in the
context of T cells influenced by the inflammatory milieu elicited
by B. abortus-infected macrophages.
It is well known that Brucella infection activates the immune
system leading to a response that favors the differentiation of T
cells toward a Th1 profile (Golding et al., 2001). This response,
which involves mainly IFN-γ-producing T cells, is considered
to be important in restraining infection (Zhan et al., 1993;
Zhan and Cheers, 1995a,b). However, taking into account that
there is increased recognition of plasticity within the T helper
lineage (Nakayamada et al., 2012), IFN-γ-producing Th1 cells
could turn into pathogenic Th17 cells under the influence of
the local inflammatory milieu generated by Brucella-infected
macrophages in the bone, leading to a pro-osteclastogenic T cell
lineage.
Influence of Brucella-Activated B Cells
on Osteoclastogenesis
The primary function of B cells is the production of antimicrobial
immunoglobulins against infecting pathogens. However, B cells
may also contribute to the proinflammatory innate host response
(Milner et al., 2005; Viau and Zouali, 2005). Activated B cells have
long lifespan, and B. abortus infection activates B cells (Goenka
et al., 2011). Also, B cells provide an infection niche for B. abortus
(Goenka et al., 2012).
B cells have a close and multifaceted relationship with bone
cells (Horowitz et al., 2010) in normal and in pathological
conditions. Infiltrating B cells into bones and joints have been
found (Young, 2008) in osteoarticular brucellosis. Taken together,
these findings suggest that B cells could contribute to infection
chronicity (Goenka et al., 2011). In this way, research on
human subjects revealed that chronic brucellar lesions on bones
and joints characteristically show, at the histological level, an
inflammatory response with varying degrees of bone destruction
and the presence of infiltrating lymphocytes (Madkour, 2001b).
Studies performed in vitro with B cells purified from murine
spleens have demonstrated that B. abortus infection induces the
expression of MMP-9, RANKL, and proinflammatory cytokines.
Besides the ability of proinflammatory cytokines and RANKL
to induce osteoclastogenesis, OPG inhibits osteoclastogenesis
induced by B cells indicating that RANKL is the main molecule
involved in the induction of bone resorption through the increase
in osteoclast differentiation (Pesce Viglietti et al., 2016).
IN VIVO MODELS OF OSTEOARTICULAR
BRUCELLOSIS
The slow progress made in defining the pathobiology of
osteoarticular brucellosis has been hampered by the absence
of a suitable animal model in which the variety of disease
manifestations observed in humans can be reproduced after
experimental infection. Despite not being natural hosts for
Brucella species that cause diseases in humans, laboratory rodents
do not either mimic the spectrum of clinical signs observed in
humans. Therefore, although the challenges of clinical brucellosis
are associated with its focal involvement, the pathophysiological
manifestations in animal models of brucellosis remain poorly
characterized.
However, until now, a few studies based on the use of murine
models have reported the dynamics of Brucella infection in bone.
In particular, knockout mice in the IFN-γ signaling pathway
have been useful as in vivo models of osteoarticular brucellosis.
In one of these models, the use of bioluminescent B. melitensis
to infect intraperitoneally interferon regulatory factor-1 (IRF-
1−/−) knockout mice enabled to identify acute infection in many
tissues, even in the tail joint (Rajashekara et al., 2005). Similar
results were obtained using B. abortus-infected IFN-γ knockout
mice (Skyberg et al., 2012). Identification of joint localization
may provide a model to understand bone pathogenesis of chronic
brucellosis in humans (Rajashekara et al., 2005). Wild type Balb/c
mice rarely develop spontaneous inflammation in synovial joints
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FIGURE 1 | Bone damage induced by soluble mediators secreted by resident and infiltrating cells upon infection with Brucella abortus. OSTEOBLAST:
B. abortus infection of osteoblast induces RANKL, MMP-2, GM-CSF, and chemokines (IL-8 and MCP-1) expression; induces apoptosis, and inhibits osteoblast
differentiation. Chemokines attract monocytes and neutrophils to the site of infection, and these cells secrete MMP-9. TNF-α secreted by B. abortus-infected
monocytes inhibits differentiation and induces apoptosis and RANKL expression in osteoblasts. It is the main cytokine involved in the secretion of MMP-9 by
monocytes. OSTEOCYTE: B. abortus infection induces MMP-2, RANKL proinflamatory cytokines, and KC secretion by osteocytes. TNF-α and RANKL from
B. abortus-infected osteocytes induce osteoclastogenesis. B. abortus infection inhibits the expression of Cx43, but does not modify integrins expression. In
contrast, supernatants from B. abortus infected macrophages inhibit Cx43 and integrins inducing osteocyte apoptosis. SYNOVIAL FIBROBLAST: B. abortus
infection induces MMP-2 and RANKL expression, and inhibits synoviocyte apoptosis through the upregulation of anti-apoptotic factors (cIAP-2, clusterin, livin, and
P21/CIP/CDNK1A) and the reduction in the expression of proteins involved in apoptosis (P-p53(S15) and TNFRI/TNFRSF1A). IMMUNE CELLS AND
OSTEOARTICULAR BRUCELLOSIS. Supernatants from B. abortus-infected macrophages induce osteoclastogenesis via TNF-α induction. T cells secrete IL-17 in
response to supernatants from B. abortus-infected macrophages, which induce osteoclastogenesis via TNF-α secreted by osteoclast precursors.
B. abortus-infected B cells secrete RANKL that induce osteoclastogenesis. L-OMP19. Brucella lipoproteins mimic responses mediated by B. abortus infection in
neutrophils, monocytes and synovial fibroblasts and these responses require TLR2.
(Adarichev et al., 2008; Farkas et al., 2009). However, Balb/c mice
infected for 26 weeks with bioluminescent B. melitensis exhibited
multiple sites of the axial skeletal involvement with inflammatory
and non-inflammatory features (Magnani et al., 2013). In these
mice, brucellosis-induced arthritis is a progressive disease with
postponed onset. In contrast, IRF-1 or IFN-γ knockout mice
(Rajashekara et al., 2005; Skyberg et al., 2012; Lacey et al., 2016)
develop arthritis much earlier, when Brucella is found in high
concentrations in the body during the acute stage of the disease.
In these conditions, inflammation and presence of bacteria was
limited to paw joints and tails (Rajashekara et al., 2005; Skyberg
et al., 2012; Lacey et al., 2016).
Despite the limitations of using animal models to study
Brucella infection, the extensive bacterial dissemination in
the murine host in the conditions indicated above raises
novel possibilities for the use of these models. Osteoarticular
complications are particularly common in Brucella-infected
humans, and the mouse model of brucellosis is particularly useful
for the use of guided imaging techniques to identify infectious
osteoarticular foci. Interestingly, inflammation and Brucella foci
were independent of the infection route, suggesting that the
osteoarticular site is a preferred location for bacterial persistence
in the host and the most inflammation-susceptible structure
(Skyberg et al., 2012).
The intra-articular knee injection of heat-killed
Brucella further suggests that joint infection can induce
a pro-inflammatory environment, with the induction of
osteoclastogenesis (Scian et al., 2011a; Delpino et al., 2012). In
Frontiers in Microbiology | www.frontiersin.org 6 February 2017 | Volume 8 | Article 256
fmicb-08-00256 February 16, 2017 Time: 16:38 # 7
Giambartolomei et al. Osteoarticular Brucellosis
addition, this approach allows corroborating in vitro findings
such as the role of TNF-α, MyD88 and TLR-2 in Brucella- induced
osteoclatogenesis (Delpino et al., 2012), and the role of T cells
in Brucella-induced osteoclastogenesis (Giambartolomei et al.,
2012). Further exploration of this model should allow us to
determine the relevant parallels to human clinical outcomes.
CONCLUDING REMARKS
Osteoarticular brucellosis is the most common localization of
active brucellosis, and bone loss has been reported consistently
in its three most frequent forms of osteoarticular involvement
(Young, 1989; Madkour, 2001a,b; Aydin et al., 2005; Colmenero
et al., 2008). Although the clinical and imaging aspects of
osteoarticular brucellosis have been widely described (Madkour,
2001a,b), the pathogenic mechanisms of bone loss caused by
Brucella have only been partially elucidated at the molecular
and cellular levels over the past ten years (Figure 1). The
findings presented in this review try to answer key questions
about the inflammatory mediators involved in osteoarticular
damage caused by Brucella and provides an initial background
for studying in more detail the role of local and infiltrating
cells in this localization of the disease. As the infection inhibits
apoptosis -or cell death- in some osteoarticular cells, it could be
possible that these cells act as reservoir of the bacteria allowing
the evolution of the disease to chronicity. This could also indicate
which cell type may be chosen for therapeutic targeting.
This knowledge could lead to the discovery of new therapeutic
treatments that could be co-administered with antibiotics to
improve the patient’s response to infection and reduce bone
damage.
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